MedPath

Methylene Blue Intra-vital Nerve Staining

Not Applicable
Conditions
Neurologic Findings
Interventions
Diagnostic Test: Methylene blue intradermal injection
Registration Number
NCT05547685
Lead Sponsor
National Taiwan University Hospital
Brief Summary

In previous studies, we know methylene blue (MB) stains nerves, and oxidized MB has near-infrared (NIR) fluorescence for fluorescent observation. In this trial we using MB on human skin and combining MB and third-harmonic generation imaging (THG) to label cutaneous nerve fibers.

Detailed Description

Intravital images were obtained before injection and then taken at 0.5, 1, 1.5, 2, 2.5, and 3 h after intradermal 0.03% (0.3 mg/mL, 1500μM) MB (10mg/mL "Astar") injection using a 0.5-mL 29-gauge insulin syringe needle (Becton, Dickinson and Company, USA). The participant lay down and the skin was imaged 10 cm above the ankle in the lower leg and above the wrist in the middle forearm; three sites in each limb were randomly selected for each time point. SHG or THG captured MB signals with two-photon excitation microscope at the Molecular Biomedical Imaging Research Center of National Taiwan University.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Healthy Volunteers
Read More
Exclusion Criteria
  • used serotonin agonist medication
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Methylene blue intradermal injectionMethylene blue intradermal injectionMethylene blue intradermal injection
Primary Outcome Measures
NameTimeMethod
intravital staining12 months

injected 10 μL of 0.03% methylene blue intradermally then calculate nerve fiber image

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Taiwan University Hosipital

🇨🇳

Taipei City, Taiwan

© Copyright 2025. All Rights Reserved by MedPath